Getty Images

Vaccine nationalism is real. But so is vaccine multilateralism.

When SARS-CoV-2 started spreading, the countries of the world had no pandemic vaccine plans in place. But a lot can happen in six months.

Today, there are 40 vaccine candidates for the coronavirus being studied in humans — including nine in the final phase of testing.

There’s also the world’s first attempt at a global effort to ensure that, when we have a working vaccine or vaccines, all countries have access, no matter their GDP.

The initiative is called Covax, and it aims to support the development and equitable distribution of 2 billion doses of Covid-19 vaccines before the end of 2021. It’s the biggest multilateral effort since the Paris climate agreement, according to Seth Berkley, the CEO of Gavi, the Vaccine Alliance, one of the partners behind Covax, along with